UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacological approaches to the challenge of treatment-resistant depression

Dialogues in clinical neuroscience, 2015-06, Vol.17 (2), p.111-126

2015

Volltextzugriff (PDF)

Evaluating the Machine Learning Literature: A Primer and User’s Guide for Psychiatrists

The American journal of psychiatry, 2021-08, Vol.178 (8), p.715-729

2021

Volltextzugriff (PDF)

A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment

The journal of clinical psychiatry, 2006-11, Vol.67 (11), p.1754-1759

2006

Volltextzugriff (PDF)

Toward achieving optimal response: understanding and managing antidepressant side effects

Dialogues in clinical neuroscience, 2008, Vol.10 (4), p.409-418

2008

Volltextzugriff (PDF)

Frontal EEG predictors of treatment outcome in major depressive disorder

European neuropsychopharmacology, 2009-11, Vol.19 (11), p.772-777

2009

Volltextzugriff (PDF)

Letter to the Editor: New onset psychosis and mania following COVID-19 infection

Journal of psychiatric research, 2020-11, Vol.130, p.177-179

2020

Volltextzugriff (PDF)

Predictors of Relapse in a Prospective Study of Fluoxetine Treatment of Major Depression

The American journal of psychiatry, 2006-09, Vol.163 (9), p.1542-1548

2006

Volltextzugriff (PDF)

S-Adenosyl Methionine (SAMe) Augmentation of Serotonin Reuptake Inhibitors for Antidepressant Nonresponders With Major Depressive Disorder: A Double-Blind, Randomized Clinical Trial

The American journal of psychiatry, 2010-08, Vol.167 (8), p.942-948

2010

Volltextzugriff (PDF)

Staff Emotional Support at Montefiore Medical Center During the COVID-19 Pandemic

Joint Commission journal on quality and patient safety, 2021-03, Vol.47 (3), p.185-189

2021

Volltextzugriff (PDF)

Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial

Journal of affective disorders, 2019-01, Vol.243, p.516-524

2019

Volltextzugriff (PDF)

Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder

The journal of clinical psychiatry, 2005-10, Vol.66 (10), p.1326-1330

2005

Volltextzugriff (PDF)

Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder

The journal of clinical psychiatry, 2004-02, Vol.65 (2), p.217-221

2004

Volltextzugriff (PDF)

The Impact of Medical Comorbidity on Acute Treatment in Major Depressive Disorder

The American journal of psychiatry, 2003-12, Vol.160 (12), p.2122-2127

2003

Volltextzugriff (PDF)

l-Methylfolate as Adjunctive Therapy for SSRI-Resistant Major Depression: Results of Two Randomized, Double-Blind, Parallel-Sequential Trials

The American journal of psychiatry, 2012-12, Vol.169 (12), p.1267-1274

2012

Volltextzugriff (PDF)

A vote for the full ticket

Bipolar disorders, 2021-02, Vol.23 (1), p.88-89

2021

Volltextzugriff (PDF)

Psychological impact of the COVID-19 pandemic on healthcare worker parents

Journal of psychosomatic research, 2023-07, Vol.170, p.111359-111359, Article 111359

2023

Volltextzugriff (PDF)

Geriatric Psychopharmacology: Pharmacokinetic and Pharmacodynamic Considerations

Psychiatric annals, 2015-07, Vol.45 (7)

2015

Volltextzugriff (PDF)

Racial and Ethnic Disparities in COVID-19-Related Stressor Exposure and Adverse Mental Health Outcomes Among Health Care Workers

The American journal of psychiatry, 2023-12, Vol.180 (12), p.896-905

2023

Volltextzugriff (PDF)

A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder

European neuropsychopharmacology, 2008-09, Vol.18 (9), p.639-645

2008

Volltextzugriff (PDF)

Difference in Treatment Outcome in Outpatients With Anxious Versus Nonanxious Depression: A STARD Report

The American journal of psychiatry, 2008-03, Vol.165 (3), p.342-351

2008

Volltextzugriff (PDF)

Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study

The journal of clinical psychiatry, 2016-06, Vol.77 (6), p.e719-e725

2016

Volltextzugriff (PDF)

Ethical and Safe Discharges from Psychiatric Units during the COVID-19 Pandemic

The journal of the American Academy of Psychiatry and the Law, 2022-06, Vol.50 (2), p.273-281

2022

Volltextzugriff (PDF)

Stretching beyond the evidence base

Bipolar disorders, 2020-06, Vol.22 (4), p.418-419

2020

Volltextzugriff (PDF)

Transcranial Photobiomodulation for the Treatment of Major Depressive Disorder. The ELATED-2 Pilot Trial

Photomedicine and laser surgery, 2018-12, Vol.36 (12), p.634-646

2018

Volltextzugriff (PDF)

Celebrating Progress, but Challenges Remain

The Psychiatric times, 2020-01, Vol.37 (1), p.2

Alpert, Jonathan E

2020

Volltextzugriff (PDF)

1 – 25 von 244

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(224)
Mit Volltextzugriff
(161)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(174)
Science & Technology
(163)
Life Sciences & Biomedicine
(161)
Psychiatry
(137)
Male
(127)
Female
(125)
Adult
(118)
Middle Aged
(101)
Biological And Medical Sciences
(98)
Medical Sciences
(95)
Psychology. Psychoanalysis. Psychiatry
(90)
Depression
(74)
Treatment Outcome
(63)
Depressive Disorder, Major - Drug Therapy
(60)
Psychopathology. Psychiatry
(57)
Psychopharmacology
(56)
Adolescent
(54)
Pharmacology. Drug Treatments
(53)
Aged
(52)
Neuropharmacology
(50)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacological approaches to the challenge of treatment-resistant depression

Evaluating the Machine Learning Literature: A Primer and User’s Guide for Psychiatrists

A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment

Toward achieving optimal response: understanding and managing antidepressant side effects

Frontal EEG predictors of treatment outcome in major depressive disorder

Letter to the Editor: New onset psychosis and mania following COVID-19 infection

Predictors of Relapse in a Prospective Study of Fluoxetine Treatment of Major Depression

S-Adenosyl Methionine (SAMe) Augmentation of Serotonin Reuptake Inhibitors for Antidepressant Nonresponders With Major Depressive Disorder: A Double-Blind, Randomized Clinical Trial

Staff Emotional Support at Montefiore Medical Center During the COVID-19 Pandemic

Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial

Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder

Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder

The Impact of Medical Comorbidity on Acute Treatment in Major Depressive Disorder

l-Methylfolate as Adjunctive Therapy for SSRI-Resistant Major Depression: Results of Two Randomized, Double-Blind, Parallel-Sequential Trials

A vote for the full ticket

Psychological impact of the COVID-19 pandemic on healthcare worker parents

Geriatric Psychopharmacology: Pharmacokinetic and Pharmacodynamic Considerations

Racial and Ethnic Disparities in COVID-19-Related Stressor Exposure and Adverse Mental Health Outcomes Among Health Care Workers

A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder

Difference in Treatment Outcome in Outpatients With Anxious Versus Nonanxious Depression: A STARD Report

Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study

Ethical and Safe Discharges from Psychiatric Units during the COVID-19 Pandemic

Stretching beyond the evidence base

Transcranial Photobiomodulation for the Treatment of Major Depressive Disorder. The ELATED-2 Pilot Trial

Celebrating Progress, but Challenges Remain

Suchergebnisse filtern